CW April 2004
Volume 13Issue Number 4 April 2004 ISSN 10593802 End in Sight for First Phase of Breast Cancer Prevention TrialThe largest breast cancer prevention trial undertaken in North America needs 1, 000 more participants to complete it. This trial is designed to determine which drug, tamoxifen or raloxifene, is more effective in preventing breast cancer with fewer side effects.
Go to Previous Page Go to Next Page Source & Additional Reading Visit www.breastcancerprevention.com to calculate your breast cancer risk or to find more information about STAR. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW April 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
